European Medicines Regulator Authorizes Pfizer COVID-19 Vaccine

AMSTERDAM (Reuters) -
Two air shipping containers of the Pfizer COVID-19 vaccine are unloaded from a UPS Boeing 757 after landing at Louisville Muhammad Ali International Airport in Louisville, Kentucky, last week. (Michael Clevenger/Pool via Reuters)

Europe’s medicines regulator on Monday approved the use of the COVID-19 vaccine jointly developed by U.S. company Pfizer and its German partner BioNTech, putting Europe on course to start inoculations within a week.

European Union countries including Germany, Austria and Italy have said they plan to start vaccinations from Dec. 27 as Europe tries to catch up with the United States and Britain where the rollout began earlier this month.